- Home
- ACON vs ADIL Comparison
ACON vs ADIL Comparison
Compare ACON & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACON
- ADIL
- Stock Information
- Founded
- ACON 2008
- ADIL 2010
- Country
- ACON United States
- ADIL United States
- Employees
- ACON N/A
- ADIL N/A
- Industry
- ACON Retail: Computer Software & Peripheral Equipment
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- ACON Technology
- ADIL Health Care
- Exchange
- ACON Nasdaq
- ADIL Nasdaq
- Market Cap
- ACON 4.2M
- ADIL 3.9M
- IPO Year
- ACON 2022
- ADIL 2018
- Fundamental
- Price
- ACON $7.28
- ADIL $0.34
- Analyst Decision
- ACON Buy
- ADIL Strong Buy
- Analyst Count
- ACON 2
- ADIL 1
- Target Price
- ACON $481.00
- ADIL $8.00
- AVG Volume (30 Days)
- ACON 15.5K
- ADIL 22.2M
- Earning Date
- ACON 08-13-2025
- ADIL 08-12-2025
- Dividend Yield
- ACON N/A
- ADIL N/A
- EPS Growth
- ACON N/A
- ADIL N/A
- EPS
- ACON N/A
- ADIL N/A
- Revenue
- ACON $54,601.00
- ADIL N/A
- Revenue This Year
- ACON $212.31
- ADIL N/A
- Revenue Next Year
- ACON $92.86
- ADIL N/A
- P/E Ratio
- ACON N/A
- ADIL N/A
- Revenue Growth
- ACON N/A
- ADIL N/A
- 52 Week Low
- ACON $6.20
- ADIL $0.22
- 52 Week High
- ACON $3,499.51
- ADIL $3.00
- Technical
- Relative Strength Index (RSI)
- ACON 42.96
- ADIL 50.21
- Support Level
- ACON $6.79
- ADIL $0.22
- Resistance Level
- ACON $7.29
- ADIL $0.27
- Average True Range (ATR)
- ACON 0.37
- ADIL 0.08
- MACD
- ACON 0.31
- ADIL -0.01
- Stochastic Oscillator
- ACON 45.79
- ADIL 53.15
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.